Cargando…

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study

BACKGROUND: It has been suggested that ergoline dopamine agonists can cause ischemic complications. The effect of dopamine agonists in general on the prevalence of ischemic events in patients with Parkinson’s disease (PD) has not been studied. OBJECTIVE: Our aim was to investigate the association be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arbouw, Maurits E. L., Movig, Kris L. L., Guchelaar, Henk-Jan, Neef, Cees, Egberts, Toine C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249169/ https://www.ncbi.nlm.nih.gov/pubmed/21779969 http://dx.doi.org/10.1007/s00228-011-1084-6

Ejemplares similares

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2022)

Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study
por: Cadogan, Cathal A., et al.
Publicado: (2021)

Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria
por: Verdoorn, Sanne, et al.
Publicado: (2015)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
por: Norberg, Helena, et al.
Publicado: (2022)

Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data
por: Stämpfli, Dominik, et al.
Publicado: (2020)

Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain
por: Lapane, Kate L., et al.
Publicado: (2020)

Developing confidence in basic prescribing skills during medical school: a longitudinal questionnaire study investigating the effects of a modified clinical pharmacology course
por: Eriksson, Anna L., et al.
Publicado: (2018)

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study
por: Rausch, Christian, et al.
Publicado: (2017)

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

The nocebo effect challenges the non-medical infliximab switch in practice
por: Boone, N. W., et al.
Publicado: (2018)

Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
por: Berbee, J. K., et al.
Publicado: (2017)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study
por: Mulder, B, et al.
Publicado: (2015)

Development and pilot testing of PHARAO—a decision support system for pharmacological risk assessment in the elderly
por: Böttiger, Ylva, et al.
Publicado: (2017)

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study
por: van Uden, Renate C. A. E., et al.
Publicado: (2021)

Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey
por: Jaspers, Tessa Corrine Catherina, et al.
Publicado: (2022)

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe
por: Ebbers, Hans C., et al.
Publicado: (2015)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

Pattern of asthma medication use among children from a large urban center in Brazil
por: Santos, Djanilson Barbosa, et al.
Publicado: (2011)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m6s6jl3anfjsktqakgcnpr5mdt